PUBLISHER: The Business Research Company | PRODUCT CODE: 1947028
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947028
Pulmonology devices encompass medical instruments and equipment employed for diagnosing, treating, and managing respiratory system conditions and diseases. These devices are essential for evaluating lung function, monitoring respiratory health, administering therapeutic interventions, and supporting patients with respiratory disorders.
Key products within the pulmonology devices market include endobronchial ultrasound (EBUS) needles, pulmonary biopsy devices, airway stents, single-use bronchoscopes, and other specialized tools. EBUS needles, utilized during bronchoscopy, are designed for collecting tissue samples from the lungs and nearby lymph nodes. They are used in various conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, tracheal and bronchial stenosis, foreign body extraction, among others. These devices find application in pulmonology clinics, hospitals, and ambulatory surgical centers.
Tariffs are impacting the pulmonology devices market by increasing costs of imported medical-grade polymers, precision components, imaging modules, and electronic subassemblies used in bronchoscopes, biopsy devices, and pulmonary testing systems. Hospitals and clinics in North America and Europe are most affected due to reliance on imported diagnostic and therapeutic devices, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are contributing to higher procurement costs and delayed equipment upgrades. However, they are also encouraging localized device manufacturing, regional supplier development, and increased investment in domestic production capabilities for critical pulmonology equipment.
The pulmonology devices market research report is one of a series of new reports from The Business Research Company that provides pulmonology devices market statistics, including pulmonology devices industry global market size, regional shares, competitors with a pulmonology devices market share, detailed pulmonology devices market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonology devices industry. This pulmonology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulmonology devices market size has grown rapidly in recent years. It will grow from $1.5 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising prevalence of respiratory diseases, increasing hospital-based pulmonary procedures, growth in diagnostic bronchoscopy adoption, expansion of pulmonology specialty clinics, availability of advanced airway management devices.
The pulmonology devices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing geriatric population with respiratory disorders, increasing demand for early lung cancer detection, rising adoption of disposable medical devices, expansion of outpatient pulmonary care, technological advancements in pulmonary diagnostics. Major trends in the forecast period include increasing adoption of single-use bronchoscopes, rising demand for minimally invasive pulmonary diagnostics, growing integration of advanced imaging-guided biopsy devices, expansion of portable pulmonary function testing equipment, enhanced focus on infection control and patient safety.
The increasing prevalence of respiratory diseases is anticipated to drive the growth of the pulmonology devices market in the future. Respiratory diseases encompass a range of medical conditions affecting organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The rise in cases of respiratory diseases is due to factors such as increasing air pollution, smoking, and occupational hazards. Pulmonology devices support respiratory disease management by enabling precise diagnosis, continuous monitoring, and effective treatment through tools such as spirometers, inhalers, pulse oximeters, and ventilators, thereby enhancing patient outcomes and quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian health and welfare agency, reported that approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, with asthma and 638,000 people, or 2.5% of the population, with chronic obstructive pulmonary disease (COPD). Therefore, the rise in respiratory disease prevalence is fueling growth in the pulmonology devices market.
Leading companies in the pulmonology devices market are focusing on developing innovative products incorporating advanced technologies to enhance patient comfort, treatment efficacy, and the management of various respiratory conditions. One such technology is bilevel positive airway pressure (BiPAP), which provides two pressure settings-one for inhalation (IPAP) and one for exhalation (EPAP)-offering more comfortable continuous pressure for users. For instance, in February 2024, ResMed, a US-based company specializing in cloud-connected medical devices, launched the AirCurve 11 series of advanced BiPAP machines. The AirCurve 11 VAuto model adjusts pressure during exhalation to align more closely with the patient's natural breathing pattern, enhancing comfort and compliance for conditions such as sleep apnea. Additionally, the AirCurve 11 ASV model utilizes adaptive servo-ventilation (ASV) technology, which monitors and adjusts ventilation 50 times per second to stabilize the patient's breathing patterns. These innovations demonstrate a commitment to improving respiratory care through cutting-edge technologies in pulmonology devices.
In January 2025, Molex LLC, a US-based electronics and manufacturing company, acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Phillips Medisize, Molex's CDMO arm, significantly strengthened its inhalation drug-delivery capabilities, enabling an expanded portfolio of combination products and device development. Vectura Group Ltd. is a UK-based pharmaceutical technology company specializing in pulmonology devices, particularly inhalation drug delivery solutions for respiratory conditions such as asthma and COPD.
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Medline Industries LP, Olympus Corporation, Omron Healthcare, ResMed, Getinge, Fisher And Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG And Co. KGaA, NIOX
North America was the largest region in the pulmonology devices market in 2025. The regions covered in the pulmonology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pulmonology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pulmonary devices market consists of sales of spirometers, peak flow meters, nebulizers, and pulse oximeters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulmonology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pulmonology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pulmonology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonology devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.